High-flow nasal cannula oxygen therapy for asthma exacerbation

Area of Science:

• Respiratory Medicine
• Critical Care
• Pediatrics

Background:

• Asthma exacerbations require effective oxygen delivery.
• Conventional oxygen therapy is standard, but novel methods are being explored.
• High-flow nasal cannula (HFNC) oxygen therapy offers potential benefits.

Purpose of the Study:

• To assess the clinical effectiveness of HFNC oxygen therapy versus conventional oxygen therapy for asthma exacerbations.
• To evaluate the safety profile of HFNC oxygen therapy in this patient population.
• To explore equity implications of HFNC oxygen therapy across different settings and populations.

Main Methods:

• This protocol outlines a Cochrane Review of interventions.
• Systematic literature search for randomized controlled trials and observational studies.
• Data synthesis and meta-analysis to compare HFNC with conventional oxygen therapy.

Main Results:

• Evidence regarding the comparative effectiveness and safety of HFNC for asthma exacerbations is currently limited.
• Further research is needed to establish optimal use and identify potential disparities.
• Analysis will focus on clinical outcomes, adverse events, and subgroup differences.

Conclusions:

• HFNC oxygen therapy is a potential alternative for managing asthma exacerbations.
• Further high-quality evidence is required to inform clinical guidelines.
• Understanding equity implications is crucial for equitable implementation.